Takeda oncology chief proposes $940K share sale

A prior 50,012-ADS sale is described as satisfying tax obligations in connection with vesting effective July 13, 2026.

Available on EDGAR 10/30/2026 - 06:38 PM EDT Accepted by SEC EDGAR 10/30/2026 - 06:38 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Takeda Pharmaceutical Company Limited is identified as the issuer in Teresa Bitetti’s notice proposing a sale of 46,609 American Depositary Shares (ADSs), with an aggregate market value of $940,103.53 and an approximate sale date of November 1, 2026. Bitetti, President, Global Oncology Business Unit, previously sold 50,012 ADSs on August 10, 2026, for $855,205.20. The notice says that sale was conducted to satisfy tax obligations in connection with share vesting effective July 13, 2026.

Key Figures

ADSs proposed for sale: 46,609 ADSs Aggregate market value of proposed sale: $940,103.53 ADSs sold: 50,012 ADSs +1 more

4 metrics

ADSs proposed for sale 46,609 ADSs Approximate sale date November 1, 2026

Aggregate market value of proposed sale $940,103.53 Proposed ADS sale

ADSs sold 50,012 ADSs August 10, 2026

Aggregate market value of ADSs sold $855,205.20 Sale on August 10, 2026

Key Terms

American Depositary Shares, Restricted Stock Unit Awards, aggregate market value, Rule 144

4 terms

American Depositary Shares financial

"American Depositary Shares (ADSs)"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Restricted Stock Unit Awards technical

"Restricted Stock Unit Awards - Vested"

Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.

aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TAK ADSs does Teresa Bitetti propose to sell?

Teresa Bitetti proposes to sell 46,609 ADSs, with an aggregate market value of $940,103.53 and an approximate sale date of November 1, 2026.

Why did Teresa Bitetti sell TAK ADSs in August 2026?

The notice says Bitetti’s sale of 50,012 ADSs on August 10, 2026 was conducted to satisfy tax obligations in connection with share vesting effective July 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001977608
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Takeda Pharmaceutical Company Limited
SEC File Number	001-38757
Address of Issuer	1-1, Nihonbashi-Honcho 2-chome Chuo-ku, Tokyo JAPAN 103-8668
Phone	81-3-3278-2111
Name of Person for Whose Account the Securities are To Be Sold	Teresa Bitetti
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	President, Global Oncology Business Unit

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares (ADSs)	Interactive Brokers LLC One Pickwick Plaza Greenwich CT 06830	46609	940103.53	198318946	11/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADSs	07/30/2024	Restricted Stock Unit Awards - Vested	Takeda Pharmaceutical Company Limited			46609	07/30/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Teresa Bitetti 40 LANDSDOWNE STREET CAMBRIDGE MA 02139	ADSs	08/10/2026	50012	855205.20

144: Remarks and Signature

Remarks	Sale during the past 3 months was conducted in order to satisfy tax obligations in connection with share vesting effective July 13, 2026.
Date of Notice	10/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kate Huleatt, by power of attorney for Teresa Bitetti
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)